ESPR vs PNW · rev $332.3M vs P/E 19, rev $2.61B
Esperion Therapeutics Inc (ESPR) versus Pinnacle West Capital Corp (PNW) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Pinnacle West Capital Corp (PNW) is a utilities - regulated electric company listed on NYSE.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported PNW revenue for 2026-06-30 was $2.61B. Net income was $215.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
ESPR currently screens at market cap $816.9M. PNW currently screens at market cap $12.41B and trailing P/E 19.1.
Not investment advice. Open the ESPR and PNW stock pages for the full models.
Not investment advice.